Cellebrite DI (CLBT) Current Deferred Revenue: 2020-2024
- Cellebrite DI's Current Deferred Revenue rose 7.99% to $262.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $262.2 million, marking a year-over-year increase of 7.99%. This contributed to the annual value of $262.2 million for FY2024, which is 7.99% up from last year.
- As of Q4 2024, Cellebrite DI's Current Deferred Revenue stood at $262.2 million, which was up 7.99% from $242.8 million recorded in Q4 2023.
- In the past 5 years, Cellebrite DI's Current Deferred Revenue registered a high of $262.2 million during Q4 2024, and its lowest value of $139.0 million during Q4 2020.
- For the 3-year period, Cellebrite DI's Current Deferred Revenue averaged around $233.3 million, with its median value being $242.8 million (2023).
- Data for Cellebrite DI's Current Deferred Revenue shows a peak YoY grew of 24.60% (in 2023) over the last 5 years.
- Cellebrite DI's Current Deferred Revenue (Quarterly) stood at $139.0 million in 2020, then climbed by 14.70% to $159.4 million in 2021, then grew by 22.25% to $194.9 million in 2022, then increased by 24.60% to $242.8 million in 2023, then grew by 7.99% to $262.2 million in 2024.
- Its Current Deferred Revenue stands at $262.2 million for Q4 2024, versus $242.8 million for Q4 2023 and $194.9 million for Q4 2022.
